The c-Jun/c-Fos complex binds to the promoter of Igha and promotes the transcription of Igha, resulting in the emergence of immunosuppressive IgA+ B cells, and thereby inhibits CTL activation and eventually facilitates MASH-driven HCC. Here, CD79A is linked to hepatocellular carcinoma.